Canada-Based Project Solace Aims To Provide Access And Data On Medical Psilocybin
TheraPsil, a Canadian coalition for psilocybin therapy legalization, together with the U.K. independent foundation Drug Science, has launched Project Solace.
Canopy Growth’s 7ACRES And Doja Launching New Cannabis Products
Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) is releasing a range of new, premium flower offerings throughout the summer from 7ACRES and Doja.
Lifeist Q2 2022 Revenue Decreases 15% YoY, Here Are The Details
Lifeist Wellness Inc.’s (OTCQB: NXTTF) (TSXV:LFST) (FRANKFURT:M5B) net revenue decreased 15% to CA$4.1 million ($3.19 million) in Q2 2022 compared to CA$4.9 million in Q2 2021.
Tilray’s Fiscal 2022 Revenue Grows 22% YoY, Here Are The Details
Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) net revenue grew 8% to $153.3 million during the fourth quarter 2022, from $142.2 million in the prior year quarter.
ICYMI: More Sustainability, Less Carbon: BMW Commits To Hemp And Recycling
Encuentra nuestro contenido en Español en El Planteo:
Manuela Castañeira, Candidata del Nuevo MAS: ‘Sobre el Cannabis Recreativo, Estuvo más Atinado L-Gante que la Derechista de Vidal’
EXCLUSIVE: Psychedelics-Assisted Psychotherapy Co. Bienstar Adds Renown Psychiatrist Dartiu Da Silveira As Scientific Advisor
Zinger Brief
Dr. Dartiu da Silveira is a renowned Brazilian psychiatrist and a pioneer in psychedelics scientific research.
Dr. Silveira will collaborate with Bienstar as a scientific advisor.
The advisor will focus on ibogaine assisted therapies protocols, medical education programs and clinical research development.
Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis
Biotech psychedelics researcher and developer Silo Pharma Inc. (OTCQB: SILO) announced its topically-administered proprietary ketamine obtained a positive outcome in a recent preclinical study.
Cannabis Conviction Is A Modern Day Scarlet Letter, Activist Weldon Angelos Says At Senate Hearing
Criminal reform and cannabis advocate Weldon Angelos, who launched The Cannabis Freedom Alliance with billionaire Charles Koch last year, told U.S.
Lexaria’s DehydraTECH CBD Hypertension Study Dosing Complete With No Serious Adverse Events
Lexaria Bioscience Corp. (NASDAQ: LEXX) (NASDAQ: LEXXW) revealed that dosing with Lexaria's DehydraTECH-processed CBD has been completed in its multi-week human clinical hypertension study HYPER-H21-4
The Flowr Corp. Completes The Sale Of KRS Research Facility For $15.9M
The Flowr Corporation (OTCPK:FLWPF) (TSX.V:FLWR) closed the sale of the Kelowna Research Station R&D Facility to Hawthorne Canada Limited for an aggregate purchase price of $15.9 million.